GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Numinus Wellness Inc (OTCPK:NMNWF) » Definitions » EV-to-EBIT

Numinus Wellness (Numinus Wellness) EV-to-EBIT : 0.00 (As of May. 16, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Numinus Wellness EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Numinus Wellness's Enterprise Value is $0.00 Mil. Numinus Wellness's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 was $-19.45 Mil. Therefore, Numinus Wellness's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Numinus Wellness's EV-to-EBIT or its related term are showing as below:

NMNWF' s EV-to-EBIT Range Over the Past 10 Years
Min: -19.11   Med: -1.7   Max: -0.47
Current: -0.9

During the past 5 years, the highest EV-to-EBIT of Numinus Wellness was -0.47. The lowest was -19.11. And the median was -1.70.

NMNWF's EV-to-EBIT is ranked worse than
100% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 18.26 vs NMNWF: -0.90

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Numinus Wellness's Enterprise Value for the quarter that ended in Feb. 2024 was $0.00 Mil. Numinus Wellness's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 was $-19.45 Mil. Numinus Wellness's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2024 was %.


Numinus Wellness EV-to-EBIT Historical Data

The historical data trend for Numinus Wellness's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Numinus Wellness EV-to-EBIT Chart

Numinus Wellness Annual Data
Trend Aug19 Aug20 Aug21 Aug22 Aug23
EV-to-EBIT
- -2.25 -6.16 -1.51 -1.71

Numinus Wellness Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.05 -1.22 -1.71 -1.33 -1.45

Competitive Comparison of Numinus Wellness's EV-to-EBIT

For the Medical Care Facilities subindustry, Numinus Wellness's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Numinus Wellness's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Numinus Wellness's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Numinus Wellness's EV-to-EBIT falls into.



Numinus Wellness EV-to-EBIT Calculation

Numinus Wellness's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/-19.452
=0.00

Numinus Wellness's current Enterprise Value is $0.00 Mil.
Numinus Wellness's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-19.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Numinus Wellness  (OTCPK:NMNWF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Numinus Wellness's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Feb. 2024 ) =EBIT / Enterprise Value (Q: Feb. 2024 )
=-19.452/0
= %

Numinus Wellness's Enterprise Value for the quarter that ended in Feb. 2024 was $0.00 Mil.
Numinus Wellness's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-19.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Numinus Wellness EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Numinus Wellness's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Numinus Wellness (Numinus Wellness) Business Description

Traded in Other Exchanges
Address
801 - 33 Water Street, Vancouver, BC, CAN, V6B 1R4
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.